SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) today announced it will report financial results for the three ...
News
- bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023
- Evoke Pharma & EVERSANA Announce Compelling Real-World Data on the Impact of ... - BioSpace
... will be presented in a poster session at today's Academy of Managed Care Pharmacy (AMCP) Annual Meeting in San Antonio, Texas.
- Celcuity Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides ...
... 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology ... Discussion at the 2022 San Antonio Breast Cancer Symposium (SABCS).
- KB Home, Worthington rise; MillerKnoll, Trupanion fall - mySA
PHOTOS: San Antonio-area home builds foundation high above ground ... The biotechnology company gave investors an encouraging update on a lung ...
- SA scored nearly $150 million in NIH funding in 2022 - San Antonio Business Journal
San Antonio secured a total of $148.4 million in National Institutes of ... nearly $29 million to the Texas Biomedical Research Institute in.